Feb 18 Watch 4:29 Rethinking how we train caregivers for people with dementia By John Yang, Harry Zahn According to the Alzheimer's Association, each year more than 11 million Americans look after family or friends with various forms of dementia, unpaid and usually untrained. The lack of proper training can negatively affect the health of these caregivers. Teepa… Continue watching
Sep 28 Watch 4:06 News Wrap: European Union says it will retaliate against attacks on energy networks In our news wrap Wednesday, the European Union says it will retaliate against attacks on its energy networks after explosions damaged two pipelines in the Baltic Sea, Palestinian authorities say Israeli forces killed four Palestinians and wounded more than 40… Continue watching
May 03 Biogen to replace CEO after Alzheimer’s drug flops By Matthew Perrone, Tom Murphy, Associated Press Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers. Continue reading
Dec 20 Biogen cuts the price tag on its Alzheimer’s drug in half By Tom Murphy, Associated Press Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000 annually. Continue reading
Jul 08 FDA trims use of contentious Alzheimer’s drug amid backlash By Matthew Perrone, Associated Press The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer's drug. Continue reading
Jun 07 Watch 6:00 Why the FDA approved a controversial Alzheimer’s drug By Amna Nawaz, Claire Mufson The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said… Continue watching
Nov 06 FDA panel urges rejection of experimental Alzheimer’s drug By Marilynn Marchione, AP Chief Medical Writer, Matthew Perrone, Associated Press The panel of outside experts for the Food and Drug Administration agreed that a pivotal study in patients failed to show “strong evidence” that the drug worked. Continue reading
Nov 25 Watch 5:34 How art can help people with Alzheimer’s enjoy the moment By Kate McDonald Nearly 6 million Americans currently live with Alzheimer’s disease, and the number continues to rise. For many, this terminal diagnosis represents the start of a life with limitations. But as a program called Contemporary Journeys shows, it's a life that… Continue watching
Nov 04 Watch 6:05 Enriching the lives of Nashville seniors, one song at a time By John Yang, Leah Nagy In Nashville, the nonprofit Music for Seniors connects the city’s musicians with its older residents in an effort to build community and improve seniors’ quality of life. Now, the organization is teaming up with researchers at Vanderbilt University to see… Continue watching
Oct 11 Watch 9:42 Can ultrasound be used to fight Alzheimer’s? By Miles O'Brien At age 61, Judi Polak is five years into a bleak diagnosis: Alzheimer’s disease. But last year she made medical history in a clinical trial, when a team of scientists, engineers and practitioners deployed a novel device to take aim… Continue watching